|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.45 USD | +3.35% |
|
-0.41% | +3.21% |
| Capitalization | 343.47Cr 294.11Cr 273.51Cr 255Cr 476.47Cr 31TCr 511.05Cr 3.15TCr 1.24TCr 15TCr 1.29TCr 1.26TCr 54TCr | P/E ratio 2025 * |
81.5x | P/E ratio 2026 * | 46x |
|---|---|---|---|---|---|
| Enterprise value | 306.84Cr 262.74Cr 244.34Cr 227.8Cr 425.65Cr 28TCr 456.54Cr 2.81TCr 1.11TCr 13TCr 1.15TCr 1.13TCr 49TCr | EV / Sales 2025 * |
6.04x | EV / Sales 2026 * | 5.19x |
| Free-Float |
99.23% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Veracyte, Inc.
| 1 day | +3.35% | ||
| 1 week | -0.41% | ||
| Current month | +3.21% | ||
| 1 month | +1.42% | ||
| 3 months | +27.46% | ||
| 6 months | +63.04% | ||
| Current year | +3.21% |
| 1 week | 41.96 |  | 46.76 |
| 1 month | 41.32 | | 46.76 |
| Current year | 41.48 | | 46.76 |
| 1 year | 22.61 | | 50.71 |
| 3 years | 18.61 | | 50.71 |
| 5 years | 14.85 | | 86.03 |
| 10 years | 4.21 | | 86.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Stapley
CEO | Chief Executive Officer | 56 | 01/06/2021 |
Rebecca Chambers
DFI | Director of Finance/CFO | 48 | 19/07/2021 |
Phillip Febbo
CTO | Chief Tech/Sci/R&D Officer | 59 | 02/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Evan Jones
BRD | Director/Board Member | 69 | 01/02/2008 |
Karin Eastham
BRD | Director/Board Member | 76 | 01/12/2012 |
Robert Epstein
CHM | Chairman | 71 | 01/05/2023 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.35% | -0.41% | +1.57% | +66.79% | 332.32Cr | |
| +0.12% | +0.61% | +74.72% | +49.15% | 1.94TCr | |
| +7.60% | +13.96% | +33.84% | -2.01% | 284.37Cr | |
| +15.86% | +12.93% | +182.66% | +89.03% | 240.6Cr | |
| +2.90% | -4.85% | +444.02% | - | 133.32Cr | |
| -2.04% | -2.04% | -58.48% | -62.96% | 97Cr | |
| +20.08% | +3.84% | -17.95% | +47.99% | 88Cr | |
| +2.56% | -1.84% | -9.09% | -14.29% | 76Cr | |
| +2.70% | -6.21% | - | - | 71Cr | |
| +0.25% | +3.96% | -20.16% | -71.45% | 57Cr | |
| Average | +5.65% | -0.08% | +70.13% | +12.78% | 331.78Cr | |
| Weighted average by Cap. | +3.01% | +0.44% | +76.69% | +42.16% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 51Cr 44Cr 40Cr 38Cr 71Cr 4.58TCr 76Cr 466.28Cr 183.28Cr 2.19TCr 190.62Cr 186.71Cr 8.04TCr | 57Cr 49Cr 45Cr 42Cr 79Cr 5.13TCr 85Cr 521.65Cr 205.05Cr 2.45TCr 213.26Cr 208.88Cr 8.99TCr |
| Net income | 4.12Cr 3.52Cr 3.28Cr 3.06Cr 5.71Cr 371.02Cr 6.12Cr 38Cr 15Cr 177.5Cr 15Cr 15Cr 650.81Cr | 7.53Cr 6.45Cr 6Cr 5.59Cr 10Cr 679.08Cr 11Cr 69Cr 27Cr 324.87Cr 28Cr 28Cr 1.19TCr |
| Net Debt | -37Cr -31Cr -29Cr -27Cr -51Cr -3.3TCr -55Cr -336.05Cr -132.1Cr -1.58TCr -137.38Cr -134.57Cr -5.79TCr | -48Cr -41Cr -38Cr -36Cr -67Cr -4.36TCr -72Cr -443.41Cr -174.3Cr -2.08TCr -181.27Cr -177.55Cr -7.64TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/26/09 | 42.04 $ | -3.49% | 12,08,103 |
| 08/26/08 | 43.56 $ | -3.44% | 5,69,288 |
| 07/26/07 | 45.11 $ | -1.16% | 6,69,576 |
| 06/26/06 | 45.64 $ | +4.61% | 8,07,820 |
Delayed Quote Nasdaq, January 13, 2026 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VCYT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition